字号·· | 护眼
南华早报

声波代替手术刀:李嘉诚将癌症疗法扩展至肾脏肿瘤Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong

点「原文对照」整页切到原文,或双击某段只看那段的原文。

香港将成为亚洲首个开展肾脏肿瘤无创治疗临床试验的城市,将该技术的应用范围从肝癌和胰腺癌扩展至肾癌,长者李嘉诚资助30名患者在三家私家医院接受治疗。

Hong Kong will become the first city in Asia to conduct clinical trials of a non-invasive treatment for kidney tumours, extending the technology beyond liver and pancreatic cancers, with tycoon Li Ka-shing funding places for 30 patients across three private hospitals.

李嘉诚基金会周三宣布,香港中大医院、港怡医院及香港养和医院将启动试验,采用组织消融技术,利用聚焦声波在无需手术切口的情况下粉碎肿瘤。

The Li Ka Shing Foundation announced on Wednesday that CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital would launch the trials using histotripsy, a technology that uses focused sound waves to break apart tumours without surgical incisions.

试验将评估该手术治疗肾癌的安全性和有效性,将该技术在香港的应用从肝脏和胰腺肿瘤延伸至肾脏。

The trials will assess the safety and effectiveness of the procedure in treating kidney cancer, extending the technology’s use in Hong Kong beyond liver and pancreatic tumours.

据基金会称,过去两年香港已有逾400名患者接受组织消融治疗。

More than 400 patients in the city have undergone histotripsy treatment over the past two years, according to the foundation.

涉及胰腺癌患者的临床试验正在港怡医院和香港中大医院进行。港怡医院自3月31日启动试验以来已完成20例胰腺肿瘤手术,香港中大医院自6月3日起已实施6例。

Clinical trials involving pancreatic cancer patients are under way at Gleneagles and CUHK Medical Centre. Gleneagles has performed 20 pancreatic tumour procedures since launching its trial on March 31, while CUHK Medical Centre has carried out six since June 3.

基金会表示,鉴于胰腺位于腹腔深处且邻近主要血管,组织消融技术为胰腺癌患者提供了另一种治疗选择。

The foundation said histotripsy offered another treatment option for pancreatic cancer patients, given the organ’s location deep within the abdomen and its proximity to major blood vessels.

全球已有逾100例胰腺癌病例通过临床试验和超说明书用药程序接受组织消融治疗,其中包括香港的病例。

More than 100 pancreatic cancer cases have been treated worldwide through clinical trials and off-label procedures, including those in Hong Kong.

自2024年以来,基金会已向香港大学李嘉诚医学院、中文大学医学院及香港养和医院捐赠三套组织消融系统。

Since 2024, the foundation has donated three histotripsy systems to the University of Hong Kong’s Li Ka Shing Faculty of Medicine, Chinese University’s Faculty of Medicine and Hong Kong Sanatorium & Hospital.

5月,基金会扩大“爱心无阻”医疗计划,在三年内资助200名合资格肝癌患者接受组织消融治疗,将费用从约26万港元降至5万港元(约6400美元)。已有20名患者在该计划下接受治疗。

In May, the foundation expanded its “Love Can Help” medical programme to subsidise histotripsy treatment for 200 eligible liver cancer patients over three years, reducing the cost from about HK$260,000 to HK$50,000 (US$6,400). Twenty patients have received treatment under the scheme.

最新公告紧随国际社会对该技术发明人、密歇根大学徐震教授的认可之后,他在9月荣获美国科学促进会颁发的2026年“金鹅奖”。

The latest announcement follows international recognition for the technology’s inventor, Professor Zhen Xu of the University of Michigan, who received the 2026 Golden Goose Award from the American Association for the Advancement of Science in September.

该奖项表彰联邦资助、为科学和社会带来重大效益的研究。徐震通过多年研究开发了这项技术,将其从实验室实验推向临床应用。

The award recognises federally funded research that has delivered significant benefits to science and society. Xu developed the technology through years of research, taking it from laboratory experiments to clinical applications.

该基金会还资助了其他医疗援助项目,包括去年推出的一项1000万港元计划,向200名癌症患者发放一次性生活津贴。

The foundation has also funded other medical assistance programmes, including a HK$10 million scheme launched last year to provide one-off living allowances to 200 cancer patients.

今年5月,该慈善机构宣布将扩大对肝癌患者的支持,在未来三年为200名患者补贴手术费,使其能以5万港元获得前沿治疗。

In May, the charity announced that it would expand support for liver cancer patients by subsidising surgery fees for 200 patients over the next three years, enabling access to cutting-edge treatment for HK$50,000.

阅读媒体原文 ↗